4.8 Article

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals

Journal

GUT
Volume 62, Issue 6, Pages 871-881

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2011-300537

Keywords

-

Funding

  1. Cancer Research UK [C348/A12076]
  2. Bobby Moore Fund
  3. Scottish Government Chief Scientist Office [K/OPR/2/2/D333, CZB/4/94]
  4. Medical Research Council [G0000657-53203]
  5. Centre Grant from CORE as part of the Digestive Cancer Campaign
  6. Foundation Dr Henri Dubois-Ferriere Dinu Lipatti
  7. German National Genome Research Network (NGFN) through the PopGen biobank [BmBF 01GR0468]
  8. National Genotyping Platform
  9. MediGrid
  10. services@medigrid projects [01AK803G, 01IG07015B]
  11. Federal Ministry of Education and Research [ZZ9603]
  12. Ministry of Cultural Affairs
  13. Social Ministry of the Federal State of Mecklenburg-West Pomerania
  14. German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, CH 117/1-1]
  15. German Federal Ministry for Education and Research [01 KH 0404]
  16. Stockholm County Council
  17. Karolinska Institute
  18. Swedish Cancer Society
  19. Stockholm Cancer Foundation
  20. Swedish Research Council
  21. Fondo de Investigacion Sanitaria/FEDER [06/1384, 06/1712, 08/0024, 08/1276]
  22. Xunta de Galicia [PGIDIT07PXIB9101209PR]
  23. Fundacion de Investigacion Medica Mutua Madrilena
  24. Ministerio de Educacion y Ciencia [SAF 07-64873]
  25. Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona)
  26. Fundacion Olga Torres
  27. Accion Transversal de Cancer (Instituto de Salud Carlos III)
  28. Instituto de Salud Carlos III
  29. Fondo de Investigacion Sanitaria [CP 03-0070]
  30. Academy of Finland (Finnish Centre of Excellence Program)
  31. Finnish Cancer Society
  32. Sigrid Juselius Foundation
  33. European Commission [9LSHG-CT-2004-512142, QLG2-CT-2001-01861]
  34. Genome Canada through the Ontario Genomics Institute
  35. Genome Quebec
  36. Ministere du Developement Economique et Regional et de la Recherche du Quebec
  37. Ontario Institute for Cancer Research
  38. National Cancer Institute of Canada (NCIC) through the Cancer Risk Assessment (CaRE) Program Project Grant
  39. Colon Cancer Family Registry and PIs
  40. National Cancer Institute, National Institutes of Health [RFA CA-95-011]
  41. Ontario Registry for Studies of Familial CRC [U01 CA076783]
  42. Cancer Research UK
  43. Bobby Moore Fund [C1298/A8362]
  44. European Union [CPRB LSHC-CT-2004-503465]
  45. CORE
  46. Oxford Biomedical Research Centre
  47. Medical Research Council
  48. Bobby Moore Cancer Cancer Research UK [C1298/A8362]
  49. St. George's Hospital
  50. [NIH/NCI U01CA122839]
  51. MRC [MC_U127527198, MC_PC_U127527198, MR/K018647/1] Funding Source: UKRI
  52. Cancer Research UK [13154, 16459, 12076, 16561] Funding Source: researchfish
  53. Cancer Research UK
  54. The Francis Crick Institute [10124] Funding Source: researchfish
  55. Medical Research Council [MC_U127527198, MC_PC_U127527198] Funding Source: researchfish

Ask authors/readers for more resources

Objective Colorectal cancer (CRC) has a substantial heritable component. Common genetic variation has been shown to contribute to CRC risk. A study was conducted in a large multi-population study to assess the feasibility of CRC risk prediction using common genetic variant data combined with other risk factors. A risk prediction model was built and applied to the Scottish population using available data. Design Nine populations of European descent were studied to develop and validate CRC risk prediction models. Binary logistic regression was used to assess the combined effect of age, gender, family history (FH) and genotypes at 10 susceptibility loci that individually only modestly influence CRC risk. Risk models were generated from case-control data incorporating genotypes alone (n=39 266) and in combination with gender, age and FH (n=11 324). Model discriminatory performance was assessed using 10-fold internal cross-validation and externally using 4187 independent samples. The 10-year absolute risk was estimated by modelling genotype and FH with age- and gender-specific population risks. Results The median number of risk alleles was greater in cases than controls (10 vs 9, p<2.2x10(-16)), confirmed in external validation sets (Sweden p=1.2x10(-6), Finland p-2x10(-5)). The mean per-allele increase in risk was 9% (OR 1.09; 95% CI 1.05 to 1.13). Discriminative performance was poor across the risk spectrum (area under curve for genotypes alone 0.57; area under curve for genotype/age/gender/FH 0.59). However, modelling genotype data, FH, age and gender with Scottish population data shows the practicalities of identifying a subgroup with >5% predicted 10-year absolute risk. Conclusion Genotype data provide additional information that complements age, gender and FH as risk factors, but individualised genetic risk prediction is not currently feasible. Nonetheless, the modelling exercise suggests public health potential since it is possible to stratify the population into CRC risk categories, thereby informing targeted prevention and surveillance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available